(Q59302473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Mechanism of nasal tolerance induced by a recombinant fragment of acetylcholine receptor for treatment of experimental myasthenia gravis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

D Barchan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

S Fuchs

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M C Souroujon

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

Journal of Neuroimmunology

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

111

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

161-168

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

Immunochemical studies on acetylcholine receptor from Torpedo californica

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Antigen-driven peripheral immune tolerance: suppression of experimental autoimmmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic protein or type II collagen.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Interferon gamma (IFN-gamma) is necessary for the genesis of acetylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Antigen-specific modulation of experimental myasthenia gravis: nasal tolerization with recombinant fragments of the human acetylcholine receptor alpha-subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

History of oral tolerance and mucosal immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Oral tolerance in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Immunotherapy in neuromuscular disorders: current and future strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

The CD40 ligand. At the center of the immune universe?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Prevention of experimental myasthenia gravis by nasal administration of synthetic acetylcholine receptor T epitope sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Nasal tolerance to experimental autoimmune myasthenia gravis: tolerance reversal by nasal administration of minute amounts of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Cellular mRNA expression of interferon-gamma (IFN-gamma), IL-4 and transforming growth factor-beta (TGF-beta) in rats nasally tolerized against experimental autoimmune myasthenia gravis (EAMG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Intranasal administration of denatured type II collagen and its fragments can delay the onset of collagen-induced arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppres

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Suppression of murine collagen-induced arthritis by nasal administration of collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Analysis and modulation of the immune response of mice to acetylcholine receptor by anti-idiotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Interaction of monoclonal antibodies to Torpedo acetylcholine receptor with the receptor of skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Quantitation of IL-1 beta mRNA by a combined method of RT-PCR and an ELISA based on ion-sensitive field effect transistor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Suppression of experimental autoimmune myasthenia gravis by oral administration of acetylcholine receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Oral tolerance for the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Mucosal tolerance: a two-edged sword to prevent and treat autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

IFN-gamma is required to induce experimental autoimmune myasthenia gravis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

Antigen-specific immunosuppression: nasal tolerance to P0 protein peptides for the prevention and treatment of experimental autoimmune neuritis in Lewis rats

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900395-7

7 January 2021

10.1016/S0165-5728(00)00395-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11063834%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference